Skip to main content

Table 2 Body weight at the beginning (day 1), middle (day 7) and final (day 15) of the treatment with 100 mg/kg (TV100), 200 mg/kg (TV200) or 400 mg/kg (TV400) of Fr-BuVt

From: Vochysia tucanorum Mart. butanol fraction presents antitumoral activity in vivo and prevents the installation of cachexia in solid Ehrlich tumor model

  Day 1 (g) Day 7 (g) Day 15 (g) Weight ratio (%)
CS 45.35 ± 1.07 46.72 ± 1.11 47.82 ± 1.31 + 5.44
TS 47.01 ± 1.17 47.55 ± 1.27 44.52 ± 1.08 − 5.29
TV100 46.79 ± 1.00 47.14 ± 1.23 46.07 ± 1.12 − 1.53
TV200 46.53 ± 1.23 48.15 ± 1.14 48.99 ± 1.17 + 5.28
TV400 47.93 ± 1.4 49.13 ± 1.39 50.09 ± 1.49 + 4.5
  1. CS (Control animals treated with saline; TS (Ehrlich carcinoma-bearing mice treated with saline); TV100 (Ehrlich carcinoma-bearing mice treated with 100 mg/kg Fr-BuVt); TV200 (Ehrlich carcinoma-bearing mice treated with 200 mg/kg Fr-BuVt); TV400 (Ehrlich carcinoma-bearing mice treated with 400 mg/kg Fr-BuVt). Values are expressed as means ± SEM. There are no significative differences between groups in the same day, one-way ANOVA followed by Holm-Sidak post hoc test.